INVA Innoviva Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INVA

Price (delayed)

$15

Market cap

$948.41M

P/E Ratio

5.45

Dividend/share

N/A

EPS

$2.75

Enterprise value

$1.2B

Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.

Highlights
Innoviva's quick ratio has soared by 177% YoY and by 6% from the previous quarter
The stock's price to earnings (P/E) is 25% less than its last 4 quarters average of 7.3 and 7% less than its 5-year quarterly average of 5.9
The gross profit is down by 16% YoY but it is up by 7% from the previous quarter
The revenue has grown by 7% from the previous quarter but it has contracted by 6% YoY
INVA's net income is down by 16% year-on-year
Innoviva's gross margin has decreased by 10% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.inva.com
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of INVA
Market
Shares outstanding
63.23M
Market cap
$948.41M
Enterprise value
$1.2B
Valuations
Price to earnings (P/E)
5.45
Price to book (P/B)
1.42
Price to sales (P/S)
3.16
EV/EBIT
5.63
EV/EBITDA
4.82
EV/Sales
3.87
Earnings
Revenue
$310.46M
EBIT
$213.26M
EBITDA
$248.96M
Free cash flow
$140.65M
Per share
EPS
$2.75
Free cash flow per share
$2.15
Book value per share
$10.53
Revenue per share
$4.74
TBVPS
$15.21
Balance sheet
Total assets
$1.24B
Total liabilities
$568.55M
Debt
$446.23M
Equity
$674.96M
Working capital
$306.09M
Liquidity
Debt to equity
0.66
Current ratio
9.03
Quick ratio
7.28
Net debt/EBITDA
1.02
Margins
EBITDA margin
80.2%
Gross margin
86.3%
Net margin
57.9%
Operating margin
35.1%
Efficiency
Return on assets
15.4%
Return on equity
29.7%
Return on invested capital
18.6%
Return on capital employed
17.7%
Return on sales
68.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INVA stock price

How has the Innoviva stock price performed over time
Intraday
-1.06%
1 week
2.11%
1 month
-0.6%
1 year
27.88%
YTD
-6.48%
QTD
-1.57%

Financial performance

How have Innoviva's revenue and profit performed over time
Revenue
$310.46M
Gross profit
$267.82M
Operating income
$108.92M
Net income
$179.72M
Gross margin
86.3%
Net margin
57.9%
INVA's operating income has shrunk by 77% YoY but it is up by 16% QoQ
The operating margin has plunged by 75% YoY but it has increased by 9% from the previous quarter
INVA's net income is down by 16% year-on-year
The gross profit is down by 16% YoY but it is up by 7% from the previous quarter

Growth

What is Innoviva's growth rate over time

Valuation

What is Innoviva stock price valuation
INVA P/E details
P/E
5.45
P/B
1.42
P/S
3.16
EV/EBIT
5.63
EV/EBITDA
4.82
EV/Sales
3.87
The stock's price to earnings (P/E) is 25% less than its last 4 quarters average of 7.3 and 7% less than its 5-year quarterly average of 5.9
The company's EPS fell by 10% YoY
The P/B is 49% below the 5-year quarterly average of 2.8 but 2.9% above the last 4 quarters average of 1.4
The equity has increased by 19% year-on-year and by 8% since the previous quarter
The P/S is 10% higher than the last 4 quarters average of 2.9 but 9% lower than the 5-year quarterly average of 3.5
The revenue has grown by 7% from the previous quarter but it has contracted by 6% YoY

Efficiency

How efficient is Innoviva business performance
The return on invested capital has surged by 142% since the previous quarter but it has declined by 28% year-on-year
The company's return on sales has surged by 134% QoQ but it fell by 23% YoY
INVA's return on equity is down by 31% year-on-year
INVA's ROA is down by 13% YoY

Dividends

What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INVA.

Financial health

How did Innoviva financials performed over time
The total assets is 119% greater than the total liabilities
Innoviva's quick ratio has soared by 177% YoY and by 6% from the previous quarter
The company's current ratio has surged by 174% YoY and by 7% QoQ
The debt is 34% less than the equity
The debt to equity has declined by 31% year-on-year and by 7% since the previous quarter
The equity has increased by 19% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.